PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
38886574,Exploiting temporal aspects of cancer immunotherapy.,Jul 2024,Rachael M Zemek,Vaccine and Infectious Disease Division,willem.lesterhuis@uwa.edu.au.
37565723,Revitalizing Cytokine-Based Cancer Immunotherapy through Advanced Delivery Systems.,Dec 2023,West Kristian Dizon Paraiso,Red Arrow Therapeutics,
26456750,Novel delivery approaches for cancer therapeutics.,10 Dec 2015,Varun Khurana,INSYS Therapeutics Inc,mitraa@umkc.edu.
36116682,Therapeutics targeting the metastatic breast cancer bone microenvironment.,Nov 2022,Sabrina J Wright-Hobart,Susan G. Komen Colorado,philip.owens@cuanschutz.edu.
25435124,Remaining challenges in childhood cancer and newer targeted therapeutics.,Feb 2015,Gregory H Reaman,Office of Hematology and Oncology Products,Malcolm.Smith@nih.gov.
38189107,Neoadjuvant personalized cancer vaccines: the final frontier?,2024,Guilhem Richard; Nicole Ruggiero; Gary D Steinberg; William D Martin; Anne S De Groot,EpiVax; EpiVax Therapeutics,
